| Literature DB >> 35371393 |
Firdos Karim1, Sudipa Chauhan1, Joydip Dhar2.
Abstract
The pandemic being a health issue at its core is a multifaceted crisis encompassing both economic and epidemic factors in a twisted tale of challenges. In counteraction, we have proposed a combined epidemic-economic model that analyses system dynamics arising in the presence of an infectious disease (SARS-2-COVID-19 in our case). Dynamical analysis of the system has been performed in context to the equilibria along with local and global stability analysis of the system simultaneously visualizing the effect on capital stabilization. The global stability analysis has been performed using graph-theoretic method. Curve-Fit has been performed for the system using optimization algorithm. The relation between all the parameters and variables involved in the model has been explored by calculating sensitivity indices which gives us the proportion that a relative change in a parameter brings to the relative change in a variable. Our findings reveal that (1) Vaccination instigates economic growth (with evidence of data obtained for 24 countries). (2) Complete vaccination leads to a considerable reduction in all infections (reduction up to 90%, as per current CDC study). (3) Excessive exposure to media can facilitate spike in infections. (4) Parameter sensitivity analysis can be of immense help in policy formation.Entities:
Year: 2022 PMID: 35371393 PMCID: PMC8963411 DOI: 10.1140/epjs/s11734-022-00539-0
Source DB: PubMed Journal: Eur Phys J Spec Top ISSN: 1951-6355 Impact factor: 2.707
Fig. 1Flow diagram of the model. Susceptible individuals S can either move to the infected class I or the vaccinated class . The susceptibles who get vaccinated with the first dose join vaccinated class at the rate of p. Individuals who recover naturally after getting infected, join the recovered class R at the rate of . Individuals who receive the second dose of vaccination after getting the first dose move towards the vaccinated class at the rate of . After receiving both the doses, individuals move towards the recovered class R at the rate of . Even after recovering from the infection naturally or getting vaccinated with both the doses, individuals from the recovered class R join back to the class of susceptibles S at the rate of owing to breakthrough infections/reinfections. Only the classes and R can join the labour force to contribute to the class of capital stock K
Variables and parameters
| Variables and parameters | Interpretation |
|---|---|
| Capital stock | |
| Size of employed population | |
| Susceptible individual density | |
| Infected individual density | |
| Recovered individual density | |
| Vaccinated individual density after first dose | |
| Vaccinated individual density after second dose | |
| Total population density | |
| Rate at which savings are performed | |
| Technological progress constant | |
| Elasticity of production | |
| Depreciation rate of capital stock | |
| Birth and death rate | |
| Rate of first dose of vaccine | |
| Rate of second dose of vaccine | |
| Rate at which vaccinated individuals get recovered | |
| Rate of infection | |
| Rate at which infected individuals recover/natural recovery rate | |
| Rate at which recovered individuals get susceptible again | |
| Effect of media |
Parametric values and their sources. Rate per day or rate/day has been calculated as (1/number of infected or recovered or vaccinated or ‘as the case may be’ individuals on a typical day). For example, if the number of people vaccinated with second dose on a typical day is 4000, then the rate/day of second dose of vaccine will be
| Parameters | Values | Source | Unit |
|---|---|---|---|
| 0.3 | [ | – | |
| 0.0035342 | [ | Births and deaths/day | |
| 0.004545 | Rate/day | ||
| 0.001 | Rate/day | ||
| 0.00909 | Rate/day | ||
| 1 | [ | – | |
| 0.5 | Assumed | – | |
| 0.62 | Assumed | Rate/day | |
| 0.2 | [ | – | |
| 140 | Assumed | – | |
| 0.0476 | [ | Rate/day | |
| 0.0011 | Rate/day | ||
| 0.5 | Assumed | – |
Fig. 2Relation between vaccinated class and Recovered class R
Sensitivity indices, , of the state variables at the endemic equilibrium, , to the parameters,
| - | ||||||
|---|---|---|---|---|---|---|
| 1.1240 | 1.0837 | |||||
| 0.7498 | ||||||
| 0 | ||||||
| 0.0042 | 0 | 0 | 0.0049 | |||
| 0.0036 | 0 | 0 | 0.0042 | |||
| 0.0026 | 0.1506 | 0 | 0 | 0.1019 | ||
| 0.0030 | 0.7197 | 0.7636 | 0.1196 | |||
| 0 | 0 | 0 | 0 | 0 | ||
| 0.1591 | 0.1867 | 0 | 0 | |||
| 0.0308 | 0.8817 | 1.0461 | 1.1336 | 1.1475 | 1.2177 | |
| 0.1130 | 0 | 0 | 0 | 0 | 0 | |
| 0.1130 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 |
Fig. 3Relation between ,R and K when rate of first dose of vaccine ‘p’ is modulated
GDP per capita (2019), GDP Per Capita (2020), GDP Per Capita (October 2021), and Vaccinated Population (November 10, 2021)
| United Arab Emirates | 43,103.3 | 38,661.176 | 43,537.689 | 98 |
| Portugal | 23,284.5 | 22,437.1 | 24,457.144 | 89 |
| Singapore | 65,640.7 | 59,797.8 | 66,263.418 | 87 |
| Spain | 29,555.3 | 27,063.2 | 30,536.858 | 82 |
| Qatar | 62,088.0 | 50,805.5 | 61,790.572 | 80 |
| Canada | 46,326.7 | 43,258.2 | 52,791.228 | 79 |
| Norway | 75,826.1 | 67,389.9 | 82,244.232 | 77 |
| Ireland | 80,886.6 | 85,267.8 | 102,394.017 | 77 |
| Italy | 33,566.8 | 31,676.2 | 35,584.882 | 77 |
| Netherlands | 52,476.3 | 52,397.1 | 57,714.876 | 76 |
| France | 40,578.6 | 39,030.4 | 45,028.265 | 76 |
| New Zealand | 42,755.2 | 41,477.9 | 45,879.609 | 74 |
| United Kingdom | 42,354.4 | 40,284.6 | 46,200.258 | 74 |
| Germany | 46,794.9 | 46,208.4 | 50,787.859 | 69 |
| United States | 65,279.5 | 63,543.6 | 69,375.375 | 67 |
| Israel | 43,588.7 | 43,610.5 | 49,840.250 | 67 |
| Switzerland | 85,334.5 | 87,097.0 | 93,515.484 | 66 |
| Iran | 3,114.6 | 2,282.6 | 12,725.042 | 65 |
| Mexico | 9,946.0 | 8,346.7 | 9,967.388 | 58 |
| India | 2,100.8 | 1,900.7 | 2,116.444 | 53 |
| Indonesia | 4,135.2 | 3,869.6 | 4,224.98 | 46 |
| Russia | 11,497.6 | 10,126.7 | 11,273.242 | 40 |
| Bangladesh | 1,855.7 | 1,968.8 | 2,138.79 | 30 |
| South Africa | 6,001.4 | 5,090.7 | 6,861.17 | 27 |
Fig. 4Association of vaccination and GDP per capita across countries
Fig. 5Relation between vaccinated class and infection I, when rate of second dose of vaccination ‘’ is modulated
Fig. 6Effect of media on infected class I and susceptible class S
Fig. 7Parameter sensitivity analysis K, R, S
Fig. 8Parameter sensitivity analysis
Fig. 9Curve fit